Repurchase Programme

Summary


M2 EQUITYBITES-August 30, 2011-Valeant Pharmaceuticals reports rise of USD300m under securities repurchase programme

(C)1994-2011 M2 COMMUNICATIONS http://www.m2.com

See the full content of this document

Extract


Repurchase Programme

The board of directors of Valeant Pharmaceut...

See the full content of this document

Sponsored links




ver las páginas en versión mobile | web

ver las páginas en versión mobile | web

© Copyright 2012, vLex. All Rights Reserved.

Contents in vLex United Kingdom

Explore vLex

For Professionals

For Partners

Company